Author:
Irawan Danny,Effendi ,Donastin Adyan,Agustiandani Rifka Windi,Tsabita Andhien Syifa’,Iryawan Rifky Dwi Aditya,Oktaviana Betta Mega,Muhammad Akbar Reza
Abstract
Introduction: The prevalence of diabetes mellitus has risen globally, posing a substantial health challenge, with a marked increase reported in both developed and developing nations. Diabetes is a primary contributor to the global prevalence of Chronic Kidney Disease (CKD). During the pandemic, there is a considerable challenge, especially for CKD patients, including a loss in health services, vulnerability to COVID-19 infection, stressful events during social distancing, and a decrease in therapy adherence. Hence, the COVID-19 pandemic may give rise to various characteristics in individuals with chronic kidney disease.
Objective: To investigate the correlation between the characteristic of patients with type 2 diabetes mellitus and the chronic kidney disease (CKD) stage at RSI Jemursari Surabaya during the COVID-19 pandemic.
Methods: An observational analytical cross-sectional study was conducted on individuals with chronic kidney disease (CKD) previously diagnosed with diabetes mellitus (DM) during the COVID-19 pandemic from 2020 to 2022. A total of 169 samples were obtained using a simple random sampling method. The variables considered include age, gender, HbA1c, blood pressure, cardiovascular comorbidities, Pulmonary comorbidities, and history of COVID-19.
Results: The study demonstrated a significant correlation between blood pressure and kidney function tests, including blood creatine level, BUN, and eGFR, with CKD stage (P<0.05). Randomised blood glucose also has a significant correlation to the CKD stage. No notable correlation was observed among age, gender, HbA1c levels, cardiovascular comorbidities, pulmonary comorbidities, and history of COVID-19.
Conclusions: The presence of hypertension and abnormal kidney function test results correlate with the stage of chronic kidney disease (CKD) during a pandemic.
Publisher
Universitas Nahdlatul Ulama Surabaya
Reference22 articles.
1. IDF Diabetes Atlas. Diabetes around the world in 2021. IDF Diabetes Atlas [Internet]. 2021; Available from: https://diabetesatlas.org
2. Carrillo-Larco RM, Barengo NC, Albitres-Flores L, Bernabe-Ortiz A. The risk of mortality among people with type 2 diabetes in Latin America: A systematic review and meta-analysis of population-based cohort studies. Diabetes Metab Res Rev. Diabetes Metab Res Rev; 2019;35(4). DOI: 10.1002/DMRR.3139
3. Regina CC, Mu’ti A, Fitriany E. Diabetes Mellitus Type 2. Verdure: Health Science Journal [Internet]. StatPearls Publishing; 2022 [cited 2023 Mar 15];3(1):8–17. Available from: https://www.ncbi.nlm.nih.gov/books/NBK513253/
4. Thomas MC, Brownlee M, Susztak K, Sharma K, Jandeleit-Dahm KAM, Zoungas S, et al.Diabetic kidney disease. Nature Reviews Disease Primers 2015 1:1. Nature Publishing Group; 2015;1(1):1–20. DOI: 10.1038/nrdp.2015.18
5. Farah RI, Al-Sabbagh MQ, Momani MS, Albtoosh A, Arabiat M, Abdulraheem AM, et al. Diabetic kidney disease in patients with type 2 diabetes mellitus: a cross-sectional study. BMC Nephrol. BioMed Central Ltd; 2021;22(1):1–8. DOI: 10.1186/S12882-021-02429- 4/FIGURES/2